Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study

BACKGROUND: Extended dosing of the erythropoiesis-stimulating agent (ESA) darbepoetin alfa (DA) once biweekly or monthly reduces anaemia treatment burden. This observational study assessed outcomes and dosing patterns in patients with chronic kidney disease not on dialysis (CKD-NoD) commencing exten...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Nephrol Dial Transplant
Main Authors: Galle, Jan-Christoph, Addison, Janet, Suranyi, Michael G., Claes, Kathleen, Di Giulio, Salvatore, Guerin, Alain, Herlitz, Hans, Kiss, István, Farouk, Mourad, Manamley, Nick, Wirnsberger, Gerhard, Winearls, Christopher
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
CLINICAL SCIENCE
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146706/
https://ncbi.nlm.nih.gov/pubmed/27190334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw047
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki